{"data":[{"accessionNo":"0001493152-26-038432","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001422142","issuerName":"Whitehawk Therapeutics, Inc.","ticker":"WHWK","cusip":"00032Q104","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Fan Yu","reportingCik":null,"personType":"IN","sharesOwned":5679253,"percentOfClass":9.4,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/whwk"},{"accessionNo":"0001493152-26-038432","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001422142","issuerName":"Whitehawk Therapeutics, Inc.","ticker":"WHWK","cusip":"00032Q104","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Ally Bridge Group Global Life Science Capital Partners V, L.P.","reportingCik":null,"personType":"PN","sharesOwned":4861314,"percentOfClass":8.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/whwk"},{"accessionNo":"0001493152-26-038432","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001422142","issuerName":"Whitehawk Therapeutics, Inc.","ticker":"WHWK","cusip":"00032Q104","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"ABG-SIV, L.P.","reportingCik":null,"personType":"PN","sharesOwned":4861314,"percentOfClass":8.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/whwk"},{"accessionNo":"0001493152-26-038432","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001422142","issuerName":"Whitehawk Therapeutics, Inc.","ticker":"WHWK","cusip":"00032Q104","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"ABG Global Life Science Capital Partners V GP, L.P.","reportingCik":null,"personType":"PN","sharesOwned":4861314,"percentOfClass":8.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/whwk"},{"accessionNo":"0001493152-26-038432","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001422142","issuerName":"Whitehawk Therapeutics, Inc.","ticker":"WHWK","cusip":"00032Q104","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"ABG V-SIV Limited","reportingCik":null,"personType":"CO","sharesOwned":4861314,"percentOfClass":8.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/whwk"},{"accessionNo":"0001493152-26-038432","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001422142","issuerName":"Whitehawk Therapeutics, Inc.","ticker":"WHWK","cusip":"00032Q104","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"ABG Global Life Science Capital Partners V GP Limited","reportingCik":null,"personType":"CO","sharesOwned":4861314,"percentOfClass":8.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/whwk"},{"accessionNo":"0000947871-26-000805","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001422142","issuerName":"Whitehawk Therapeutics, Inc.","ticker":"WHWK","cusip":"00032Q104","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"OrbiMed Advisors LLC","reportingCik":null,"personType":"IA","sharesOwned":3934296,"percentOfClass":7.3,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/whwk"},{"accessionNo":"0000947871-26-000805","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001422142","issuerName":"Whitehawk Therapeutics, Inc.","ticker":"WHWK","cusip":"00032Q104","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"OrbiMed Genesis GP LLC","reportingCik":null,"personType":"OO","sharesOwned":3934296,"percentOfClass":7.3,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/whwk"},{"accessionNo":"0001493152-26-038432","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001422142","issuerName":"Whitehawk Therapeutics, Inc.","ticker":"WHWK","cusip":"00032Q104","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"ABG Management Ltd.","reportingCik":null,"personType":"CO","sharesOwned":817939,"percentOfClass":1.4,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/whwk"},{"accessionNo":"0001493152-26-038432","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001422142","issuerName":"Whitehawk Therapeutics, Inc.","ticker":"WHWK","cusip":"00032Q104","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Ally Bridge Group (NY) LLC","reportingCik":null,"personType":"OO","sharesOwned":817939,"percentOfClass":1.4,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/whwk"},{"accessionNo":"0001493152-26-038432","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001422142","issuerName":"Whitehawk Therapeutics, Inc.","ticker":"WHWK","cusip":"00032Q104","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Ally Bridge MedAlpha Master Fund L.P.","reportingCik":null,"personType":"PN","sharesOwned":817939,"percentOfClass":1.4,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/whwk"},{"accessionNo":"0001493152-26-038432","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001422142","issuerName":"Whitehawk Therapeutics, Inc.","ticker":"WHWK","cusip":"00032Q104","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"ABG Innovation-SO Limited","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/whwk"},{"accessionNo":"0001493152-26-038432","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001422142","issuerName":"Whitehawk Therapeutics, Inc.","ticker":"WHWK","cusip":"00032Q104","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Ally Bridge Group Innovation Capital Partners III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/whwk"},{"accessionNo":"0001493152-26-038432","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001422142","issuerName":"Whitehawk Therapeutics, Inc.","ticker":"WHWK","cusip":"00032Q104","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"ABG Innovation Capital Partners III GP, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/whwk"},{"accessionNo":"0001493152-26-038432","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001422142","issuerName":"Whitehawk Therapeutics, Inc.","ticker":"WHWK","cusip":"00032Q104","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"ABG Innovation Capital Partners III GP Limited","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/whwk"},{"accessionNo":"0000935836-26-000289","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001422142","issuerName":"Whitehawk Therapeutics, Inc.","ticker":"WHWK","cusip":"00032Q104","securityClass":"Common Stock","eventDate":"2026-05-14","reportingPerson":"ANUPAM DALAL","reportingCik":null,"personType":"IN,HC","sharesOwned":4843775,"percentOfClass":9,"filedAt":"2026-05-18","canonicalUrl":"https://xoomar.com/markets/stocks/whwk"},{"accessionNo":"0000935836-26-000289","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001422142","issuerName":"Whitehawk Therapeutics, Inc.","ticker":"WHWK","cusip":"00032Q104","securityClass":"Common Stock","eventDate":"2026-05-14","reportingPerson":"ACUTA CAPITAL PARTNERS, LLC","reportingCik":"0001582844","personType":"IA,OO","sharesOwned":4685912,"percentOfClass":8.7,"filedAt":"2026-05-18","canonicalUrl":"https://xoomar.com/markets/stocks/whwk"},{"accessionNo":"0000935836-26-000289","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001422142","issuerName":"Whitehawk Therapeutics, Inc.","ticker":"WHWK","cusip":"00032Q104","securityClass":"Common Stock","eventDate":"2026-05-14","reportingPerson":"Acuta Capital Fund, LP","reportingCik":null,"personType":"PN","sharesOwned":3538288,"percentOfClass":6.6,"filedAt":"2026-05-18","canonicalUrl":"https://xoomar.com/markets/stocks/whwk"},{"accessionNo":"0000902664-26-002450","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001422142","issuerName":"Whitehawk Therapeutics, Inc.","ticker":"WHWK","cusip":"00032Q104","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-05-12","reportingPerson":"Avoro Capital Advisors LLC","reportingCik":"0001633313","personType":"IA,OO","sharesOwned":15893516,"percentOfClass":19.99,"filedAt":"2026-05-14","canonicalUrl":"https://xoomar.com/markets/stocks/whwk"},{"accessionNo":"0000902664-26-002450","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001422142","issuerName":"Whitehawk Therapeutics, Inc.","ticker":"WHWK","cusip":"00032Q104","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-05-12","reportingPerson":"Behzad Aghazadeh","reportingCik":"0001701815","personType":"IN","sharesOwned":18292675,"percentOfClass":19.99,"filedAt":"2026-05-14","canonicalUrl":"https://xoomar.com/markets/stocks/whwk"},{"accessionNo":"0000902664-26-002450","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001422142","issuerName":"Whitehawk Therapeutics, Inc.","ticker":"WHWK","cusip":"00032Q104","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-05-12","reportingPerson":"Avoro Ventures LLC","reportingCik":"0001879253","personType":"IA,OO","sharesOwned":2288950,"percentOfClass":4.1,"filedAt":"2026-05-14","canonicalUrl":"https://xoomar.com/markets/stocks/whwk"}],"updatedAt":"2026-11-05T16:31:12.524Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/whwk","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}